EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the <i>RIP3</i> promoter
Feng Shi(Taiwan Centers for Disease Control), Ya Cao(Shanghai University), Ann M. Bode(University of Minnesota), Jian Zhou(Shenzhen University Health Science Center), Longlong Xie(Central South University), Xiangjian Luo(Central South University), Wei‐Zhong Wu(Ministry of Education), Shuang–Jian Qiu(Fudan University), Jia Fan(Nanjing Tech University), Min Tang(Central South University), Shang Li(University of Science and Technology of China), Qianqian Du(Central South University), Min Zhou(Central South University), Xiaolan Liu(Qiqihar University), Yueshuo Li(Central South University), Xin Zhang(Wuhan University), Qiang Gao(Northeastern University)
Cited by 57
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644